{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T09:11:41Z","timestamp":1771578701643,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,12,4]],"date-time":"2017-12-04T00:00:00Z","timestamp":1512345600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s11606-017-4233-5","type":"journal-article","created":{"date-parts":[[2017,12,4]],"date-time":"2017-12-04T20:38:32Z","timestamp":1512419912000},"page":"358-366","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Effects of Discontinuation of Urate-Lowering Therapy: A Systematic Review"],"prefix":"10.1007","volume":"33","author":[{"given":"Virginie","family":"Beslon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Perrine","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annabel","family":"Maruani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hubert","family":"Maisonneuve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Giraudeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Pascal","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,4]]},"reference":[{"issue":"4","key":"4233_CR1","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1592\/phco.28.4.437","volume":"28","author":"BA Briesacher","year":"2008","unstructured":"Briesacher BA, Andrade SE, Fouayzi H, Chan KA. Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy. 2008;28(4):437\u201343. \n                    https:\/\/doi.org\/10.1592\/phco.1.4.437\n                    \n                  .","journal-title":"Pharmacotherapy"},{"issue":"5","key":"4233_CR2","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.semarthrit.2008.01.011","volume":"38","author":"LR Harrold","year":"2009","unstructured":"Harrold LR, Andrade SE. Medication adherence of patients with selected rheumatic conditions: a systematic review of the literature. Semin Arthritis Rheum. 2009;38(5):396\u2013402. \n                    https:\/\/doi.org\/10.1016\/j.semarthrit.2008.01.011\n                    \n                  .","journal-title":"Semin Arthritis Rheum"},{"issue":"10","key":"4233_CR3","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1002\/acr.22336","volume":"66","author":"MA Vera De","year":"2014","unstructured":"De Vera MA, Marcotte G, Rai S, Galo JS, Bhole V. Medication adherence in gout: a systematic review. Arthritis Care Res. 2014;66(10):1551\u20139. \n                    https:\/\/doi.org\/10.1002\/acr.22336\n                    \n                  .","journal-title":"Arthritis Care Res"},{"issue":"5","key":"4233_CR4","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1136\/ard.2007.076182","volume":"67","author":"DH Solomon","year":"2008","unstructured":"Solomon DH, Avorn J, Levin R, Brookhart MA. Uric acid lowering therapy: prescribing patterns in a large cohort of older adults. Ann Rheum Dis. 2008;67(5):609\u201313. \n                    https:\/\/doi.org\/10.1136\/ard.2007.076182\n                    \n                  .","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"4233_CR5","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1093\/rheumatology\/kes431","volume":"52","author":"G Zandman-Goddard","year":"2013","unstructured":"Zandman-Goddard G, Amital H, Shamrayevsky N, Raz R, Shalev V, Chodick G. Rates of adherence and persistence with allopurinol therapy among gout patients in Israel. Rheumatol Oxf Engl. 2013;52(6):1126\u201331. \n                    https:\/\/doi.org\/10.1093\/rheumatology\/kes431\n                    \n                  .","journal-title":"Rheumatol Oxf Engl"},{"issue":"4","key":"4233_CR6","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1177\/1742395310378761","volume":"6","author":"LR Harrold","year":"2010","unstructured":"Harrold LR, Mazor KM, Velten S, Ockene IS, Yood RA. Patients and providers view gout differently: a qualitative study. Chronic Illn. 2010;6(4):263\u201371. \n                    https:\/\/doi.org\/10.1177\/1742395310378761\n                    \n                  .","journal-title":"Chronic Illn"},{"issue":"2","key":"4233_CR7","doi-asserted-by":"publisher","first-page":"R82","DOI":"10.1186\/ar4524","volume":"16","author":"JA Singh","year":"2014","unstructured":"Singh JA. Facilitators and barriers to adherence to urate-lowering therapy in African-Americans with gout: a qualitative study. Arthritis Res Ther. 2014;16(2):R82. \n                    https:\/\/doi.org\/10.1186\/ar4524\n                    \n                  .","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"4233_CR8","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s10067-015-3039-2","volume":"35","author":"P Chandratre","year":"2016","unstructured":"Chandratre P, Mallen CD, Roddy E, Liddle J, Richardson J. \u201cYou want to get on with the rest of your life\u201d: a qualitative study of health-related quality of life in gout. Clin Rheumatol. 2016;35(5):1197\u20131205. \n                    https:\/\/doi.org\/10.1007\/s10067-015-3039-2\n                    \n                  .","journal-title":"Clin Rheumatol"},{"issue":"8","key":"4233_CR9","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1007\/s10067-016-3212-2","volume":"35","author":"B Spaetgens","year":"2016","unstructured":"Spaetgens B, Pustjens T, Scheepers LEJM, Janssens HJEM, van der Linden S, Boonen A. Knowledge, illness perceptions and stated clinical practice behaviour in management of gout: a mixed methods study in general practice. Clin Rheumatol. 2016;35(8):2053-2061. \n                    https:\/\/doi.org\/10.1007\/s10067-016-3212-2\n                    \n                  .","journal-title":"Clin Rheumatol"},{"issue":"9","key":"4233_CR10","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1046\/j.1445-2197.2003.02748.x","volume":"73","author":"K Slim","year":"2003","unstructured":"Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J. Methodological index for non-randomized studies (MINORS): development and validation of a new instrument. ANZ J Surg. 2003;73(9):712\u20136.","journal-title":"ANZ J Surg"},{"issue":"11","key":"4233_CR11","first-page":"2437","volume":"30","author":"J Darmawan","year":"2003","unstructured":"Darmawan J, Rasker JJ, Nuralim H. The effect of control and self-medication of chronic gout in a developing country. Outcome after 10 years. J Rheumatol. 2003;30(11):2437\u201343.","journal-title":"J Rheumatol"},{"issue":"4","key":"4233_CR12","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1136\/ard.33.4.304","volume":"33","author":"WY Loebl","year":"1974","unstructured":"Loebl WY, Scott JT. Withdrawal of allopurinol in patients with gout. Ann Rheum Dis. 1974;33(4):304\u20137. \n                    https:\/\/doi.org\/10.1136\/ard.33.4.304\n                    \n                  .","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"4233_CR13","first-page":"1383","volume":"20","author":"MF Lieshout-Zuidema van","year":"1993","unstructured":"van Lieshout-Zuidema MF, Breedveld FC. Withdrawal of longterm antihyperuricemic therapy in tophaceous gout. J Rheumatol 1993;20(8):1383\u20135.","journal-title":"J Rheumatol"},{"issue":"1","key":"4233_CR14","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/BF02201004","volume":"6","author":"LF Gast","year":"1987","unstructured":"Gast LF. Withdrawal of longterm antihyperuricemic therapy in tophaceous gout. Clin Rheumatol 1987;6(1):70\u20133. \n                    https:\/\/doi.org\/10.1007\/BF02201004\n                    \n                  .","journal-title":"Clin Rheumatol"},{"issue":"12","key":"4233_CR15","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.1002\/art.30649","volume":"63","author":"F Perez-Ruiz","year":"2011","unstructured":"Perez-Ruiz F, Herrero-Beites AM, Carmona L. A two-stage approach to the treatment of hyperuricemia in gout: the \u201cdirty dish\u201d hypothesis. Arthritis Rheum 2011;63(12):4002\u20136. \n                    https:\/\/doi.org\/10.1002\/art.30649\n                    \n                  .","journal-title":"Arthritis Rheum"},{"issue":"3","key":"4233_CR16","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/art.1780200320","volume":"20","author":"SL Wallace","year":"1977","unstructured":"Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Y\u00fc TF. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977;20(3):895\u2013900.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"4233_CR17","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/0090-4295(90)80235-F","volume":"36","author":"K Kohri","year":"1990","unstructured":"Kohri K, Kodama M, Katayama Y, et al. Allopurinol and thiazide effects on new urinary stone formed after discontinued therapy in patients with urinary stones. Urology 1990;36(4):309\u201314.","journal-title":"Urology"},{"issue":"1","key":"4233_CR18","first-page":"8","volume":"21","author":"A Jabor","year":"1996","unstructured":"Jabor A. Kidney stone clinic: ten years of experience. Ned Tijdschr Klin Chem 1996;21(1):8\u201310.","journal-title":"Ned Tijdschr Klin Chem"},{"issue":"5","key":"4233_CR19","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1159\/000105142","volume":"27","author":"KM Talaat","year":"2007","unstructured":"Talaat KM, el-Sheikh AR. The effect of mild hyperuricemia on urinary transforming growth factor beta and the progression of chronic kidney disease. Am J Nephrol 2007;27(5):435\u201340. \n                    https:\/\/doi.org\/10.1159\/000105142\n                    \n                  .","journal-title":"Am J Nephrol"},{"issue":"Suppl 10","key":"4233_CR20","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/art.30649","volume":"62","author":"F Perez-Ruiz","year":"2010","unstructured":"Perez-Ruiz F, Herrero-Beites AM, Miguel A. Serum urate levels have an impact on renal function in patients with gout withdrawing urate-lowering therapy (ULT). Arthritis Rheum 2010;62(Suppl 10):159. \n                    https:\/\/doi.org\/10.1002\/art.30649\n                    \n                  .","journal-title":"Arthritis Rheum"},{"issue":"5","key":"4233_CR21","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1161\/hy1101.092839","volume":"38","author":"M Mazzali","year":"2001","unstructured":"Mazzali M, Hughes J, Kim YG, et al. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 2001;38(5):1101\u20136.","journal-title":"Hypertension"},{"key":"4233_CR22","volume-title":"Management of Gout","author":"PG Shekelle","year":"2016","unstructured":"Shekelle PG, FitzGerald J, Newberry SJ, et al. Management of Gout. Rockville: Agency for Healthcare Research and Quality (US); 2016. \n                    http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK356141\/\n                    \n                  . Accessed February 16, 2017."},{"issue":"8","key":"4233_CR23","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1093\/rheumatology\/keh679","volume":"44","author":"TR Mikuls","year":"2005","unstructured":"Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Saag KG. Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD). Rheumatol Oxf Engl 2005;44(8):1038-1042. \n                    https:\/\/doi.org\/10.1093\/rheumatology\/keh679\n                    \n                  .","journal-title":"Rheumatol Oxf Engl"},{"issue":"12","key":"4233_CR24","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1007\/s00228-014-1752-4","volume":"70","author":"L Pasina","year":"2014","unstructured":"Pasina L, Brucato AL, Djade CD, et al. Inappropriate prescription of allopurinol and febuxostat and risk of adverse events in the elderly: results from the REPOSI registry. Eur J Clin Pharmacol 2014;70(12):1495\u20131503. \n                    https:\/\/doi.org\/10.1007\/s00228-014-1752-4\n                    \n                  .","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"4233_CR25","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jbspin.2014.02.012","volume":"81","author":"C Banse","year":"2014","unstructured":"Banse C, Fardellone P, Paccou J. Prevalence of treatment of hyperuricemic in patients admitted to the Rheumatology ward and evaluation of compliance with the 2012 ACR Guidelines. Joint Bone Spine Rev Rhum 2014;81(5):461\u20132. \n                    https:\/\/doi.org\/10.1016\/j.jbspin.2014.02.012\n                    \n                  .","journal-title":"Joint Bone Spine Rev Rhum"},{"issue":"6","key":"4233_CR26","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.semarthrit.2010.07.001","volume":"40","author":"JA Singh","year":"2011","unstructured":"Singh JA, Sarkin A, Shieh M, et al. Health Care Utilization in Patients with Gout. Semin Arthritis Rheum 2011;40(6):501\u201311. \n                    https:\/\/doi.org\/10.1016\/j.semarthrit.2010.07.001\n                    \n                  .","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"4233_CR27","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1016\/j.clinthera.2016.05.007","volume":"38","author":"LJ Smolen","year":"2016","unstructured":"Smolen LJ, Gahn JC, Mitri G, Shiozawa A. The Budget Impact of Increased Use of Febuxostat in the Management of Gout: A US Health Plan Managed Care Pharmacy and Medical Costs Perspective. Clin Ther 2016;38(7):1710\u201325. \n                    https:\/\/doi.org\/10.1016\/j.clinthera.2016.05.007\n                    \n                  .","journal-title":"Clin Ther"},{"issue":"12","key":"4233_CR28","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1002\/acr.22067","volume":"65","author":"SC Kim","year":"2013","unstructured":"Kim SC, Schmidt BMW, Franklin JM, Liu J, Solomon DH, Schneeweiss S. Clinical and health care use characteristics of patients newly prescribed allopurinol, febuxostat and colchicine for gout. Arthritis Care Res 2013;65(12):2008\u201314. \n                    https:\/\/doi.org\/10.1002\/acr.22067\n                    \n                  .","journal-title":"Arthritis Care Res"}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11606-017-4233-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-017-4233-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-017-4233-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T15:34:07Z","timestamp":1544456047000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11606-017-4233-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,4]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["4233"],"URL":"https:\/\/doi.org\/10.1007\/s11606-017-4233-5","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,4]]}}}